Five priorities of African genomics research: the next frontier

A Wonkam, NS Munung, C Dandara… - Annual Review of …, 2022 - annualreviews.org
To embrace the prospects of accurately diagnosing thousands of monogenic conditions,
predicting disease risks for complex traits or diseases, tailoring treatment to individuals' …

[PDF][PDF] Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review.

EB Tata, MA Ambele, MS Pepper - Precision Medicine, 2020 - mdpi.com
Clinical research in high-income countries is increasingly demonstrating the
costeffectiveness of clinical pharmacogenetic (PGx) testing in reducing the incidence of …

[HTML][HTML] African Pharmacogenomics Consortium: consolidating pharmacogenomics knowledge, capacity development and translation in Africa: consolidating …

C Dandara, C Masimirembwa, YZ Haffani… - AAS Open …, 2019 - ncbi.nlm.nih.gov
Abstract The African Pharmacogenomics Consortium (APC) was formally launched on the
6th September 2018. This white paper outlines its vision, and objectives towards addressing …

[HTML][HTML] When the same treatment has different response: The role of pharmacogenomics in statin therapy

E Zheng, P Madura, J Grandos, M Broncel… - Biomedicine & …, 2024 - Elsevier
Statins, also known as HMG-CoA reductase inhibitors, are one of the most potently
prescribed and thoroughly researched medications, predominantly utilized for managing …

[HTML][HTML] Genetic variability and population diversity of the human SLCO (OATP) transporter family

B Zhang, VM Lauschke - Pharmacological research, 2019 - Elsevier
Organic anion transporting polypeptides (OATP) encoded by the SLCO gene family
constitute clinically important transporters involved in the disposition of endogenous …

Warfarin pharmacogenomics for precision medicine in real-life clinical practice in southern Africa: Harnessing 73 variants in 29 pharmacogenes

S Muyambo, A Ndadza, ND Soko, B Kruger… - OMICS: A Journal of …, 2022 - liebertpub.com
Pharmacogenomics is universally relevant for worldwide modern therapeutics and yet
needs further development in resource-limited countries. While there is an abundance of …

[HTML][HTML] Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME …

C Özvegy-Laczka, O Ungvári, É Bakos - Biochemical Pharmacology, 2023 - Elsevier
In humans, approximately 70% of drugs are eliminated through the liver. This process is
governed by the concerted action of membrane transporters and metabolic enzymes …

Major genetic drivers of statin treatment response in African populations and pharmacogenetics of dyslipidemia through a One Health lens

Z Lusiki, D Blom, ND Soko, S Malema… - OMICS: A Journal of …, 2024 - liebertpub.com
A One Health lens is increasingly significant to address the intertwined challenges in
planetary health concerned with the health of humans, nonhuman animals, plants, and …

Towards evidence-based implementation of pharmacogenomics in southern Africa: comorbidities and polypharmacy profiles across diseases

ND Soko, S Muyambo, MTL Dandara… - Journal of Personalized …, 2023 - mdpi.com
Pharmacogenomics may improve patient care by guiding drug selection and dosing;
however, this requires prior knowledge of the pharmacogenomics of drugs commonly used …

[HTML][HTML] Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with Familial …

C Dagli-Hernandez, RCC de Freitas… - Annals of …, 2021 - ncbi.nlm.nih.gov
Statins are the most widely used cholesterol-lowering drugs for cardiovascular diseases
prevention. However, some patients are refractory to treatment, whereas others experience …